Home / Pre Event  / ASSOCHAM 2nd Conference on Lung Cancer – Enabling Innovations in Treatment Pathways | 30th Nov, 2023 | New Delhi

ASSOCHAM 2nd Conference on Lung Cancer – Enabling Innovations in Treatment Pathways | 30th Nov, 2023 | New Delhi

Lung cancer has evolved into a formidable health challenge in India and addressing this crisis requires a multi-pronged approach, including tobacco control, air quality improvement, early detection, and advancements in treatment. It is essential for

Lung cancer has evolved into a formidable health challenge in India and addressing this crisis requires a multi-pronged approach, including tobacco control, air quality improvement, early detection, and advancements in treatment. It is essential for healthcare authorities, policymakers, and communities to work collaboratively to alleviate the growing burden of lung cancer in India and enhance the well-being of affected individuals.

With a rising burden of lung cancer in India, early detection and personalized treatment pathways are crucial for improving survival rates. The need for innovation arises from the urgency to counter the increasing impact of lung cancer on public health and individual lives.

During the Lung Cancer Awareness Month, with an objective to address the complexity of the disease, improve survival rates, reduce side effects, and enhance the overall patient experience, ASSOCHAM is organizing a 2nd Conference on “Lung Cancer – Enabling Innovations in Treatment Pathways” on Thursday, 30th November 2023 at New Delhi.

Invited Speakers:

  • Ms. L.S. Changsan, Additional Secretary & Mission Director (NHM), Ministry of Health & Family Welfare, Govt. of India
  • Dr. Shalini Singh, Director, ICMR-National Institute of Cancer Prevention and Research, Ministry of Health and Family Welfare, Government of India
  • Dr. Sant Ram, Director (Medical), Employees’ State Insurance Corporation, Ministry of Labour & Employment, Government of India
  • Dr. Sunny Swarnkar, DADG(SS), Directorate General of Health Services, Ministry of Health & Family Welfare, Govt. of India
  • Mr. Randip Singh Jagpal, Executive Director, Insurance Regulatory and Development Authority of India, Government of India
  • Dr. Roderico H Ofrin, WHO Representative of India
  • Dr. Manoj Jain, Director, CGHS, Ministry of Health & Family Welfare, Govt. of India
  • Dr. Abhishek Shankar, Associate Professor, Department of Radiation Oncology, All India Institute of Medical Sciences
  • Dr. Nitesh Rohtagi, Senior Director Medical Oncologist, Fortis Memorial Research Institute, Gurugram
  • Dr. Jayanta Chakrabarti, Director, Chittaranjan National Cancer Institute, Kolkata, West Bengal
  • Dr. Diptirani Samant, Professor – Medical Oncology, Acharya Harihar Regional Cancer Institute, Cuttack, Odisha
  • Mr. Chander Shekhar Sibal, Sr. Vice President, Fujifilm India Pvt. Ltd.
  • Ms. Neelima Dwivedi, Senior Director – External Affairs (Market Access, Communications, Policy and Government Affairs), MSD Pharmaceutical Pvt. Ltd.
  • Dr. Maulik Choksi, Deputy Country Director (Technical), Access Health International
  • Mr. Vivek Sharma, Founder, Director – UHAPO
  • Dr. Sachin Kumar, Scientist II, Dept. of Medical Oncology, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi
  • Dr. Mukesh Patekar, Unit Head, Medical Oncology, Artemis Hospital Gurugram
  • (Padmashri) Prof. (Dr.) D. S. Rana, Chairperson, ASSOCHAM National Healthcare Council and Board of Trustees, Sir Ganga Ram Hospital
  • Dr. D K Gupta, Co- Chairperson, ASSOCHAM National Digital Healthcare Taskforce and Chairman & Managing Director, Felix Hospital
  • Dr. Sudhir Kalhan, Chairperson, ASSOCHAM National Digital Healthcare Taskforce and Chairman, Institute of Minimal Access, Metabolic & Bariatric Surgery, Sir Ganga Ram Hospital

medgatetoday@gmail.com

Review overview
NO COMMENTS

POST A COMMENT